# FMC Corp: Form 10-Q for the period ended Sep 29, 2017

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2017-11-07
- Accepted by EDGAR: Nov 7, 2017, 15:33 ET
- Period: 2017-09-29
- Accession: 0000037785-17-000067
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778517000067/fmc09301710q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778517000067/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-09-29.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 9 months, 2017-01-01 to 2017-09-30 | $1.90bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2017-07-01 to 2017-09-30 | $380.3m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2017-01-01 to 2017-09-30 | $1.18bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2017-07-01 to 2017-09-30 | $265.9m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2017-01-01 to 2017-09-30 | $716.5m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2017-07-01 to 2017-09-30 | $150.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2017-01-01 to 2017-09-30 | $387.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-07-01 to 2017-09-30 | $77.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2017-01-01 to 2017-09-30 | $216.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2017-07-01 to 2017-09-30 | −$11.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2017-01-01 to 2017-09-30 | $1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-07-01 to 2017-09-30 | $55.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2017-01-01 to 2017-09-30 | $5.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-07-01 to 2017-09-30 | $0.41 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2017-01-01 to 2017-09-30 | $0.04 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-07-01 to 2017-09-30 | $0.41 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2017-01-01 to 2017-09-30 | $0.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-07-01 to 2017-09-30 | 135,947,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2017-01-01 to 2017-09-30 | 135,508,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2017-01-01 to 2017-09-30 | $272.5m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2017-01-01 to 2017-09-30 | $37.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2017-01-01 to 2017-09-30 | $66.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2017-09-30 | $93.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-09-30 | $3.57bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-09-30 | $6.06bn | us-gaap:Assets |
| Current liabilities | at 2017-09-30 | $1.63bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2017-09-30 | $1.49bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2017-09-30 | $105.7m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2017-09-30 | $108.5m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2017-09-30 | $2.12bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2017-09-30 | 134,261,782 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 57,300 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expect”, “expects”, “should”, “could”, “may”, “will continue to”, “believe”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2016 (the “2016 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2016 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Critical Accounting Policies” section in our 2016 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Revenue recognition and trade receivables
- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets and indefinite-lived assets
- Pensions and other postretirement benefits
- Income taxes

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to the condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in two distinct business segments: FMC Agricultural Solutions and FMC Lithium. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals: insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. Our FMC Lithium segment manufactures lithium for use in a wide range of lithium products, which are used primarily in energy storage, specialty polymers and chemical synthesis applications.

### Third Quarter 2017 Highlights

On November 1, 2017, we completed the acquisition of certain assets relating to DuPont's Crop Protection Business. Separately, we sold to DuPont our FMC Health and Nutrition segment and also paid $1.2 billion in cash.

The following are the more significant developments in our businesses during the three months ended September 30, 2017:

- Revenue of $646.2 million for the three months ended September 30, 2017 increased $17.4 million or 3 percent versus the same period last year. The increase in revenue was primarily attributable to FMC Lithium. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in Asia decreased 17 percent period over period while sales in North America increased by 15 percent, sales in Latin America increased 12 percent, and sales in Europe, Middle East and Africa increased by 2 percent.
- Our gross margin of $265.9 million increased versus the prior year's third quarter by $51.3 million. Gross margin percent of 41 percent also increased compared to 34 percent in the prior year primarily due to lower costs within FMC Agricultural Solutions and higher prices in FMC Lithium.
- Selling, general and administrative expenses, excluding acquisition-related charges and non-operating pension and postretirement charges, increased by approximately $10.4 million or 11 percent to $105.7 million due to higher corporate costs, primarily employee related incentives.
- Research and development expenses of $30.2 million decreased $0.4 million or 1 percent.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $95.4 million increased compared to the prior year amount of $58.7 million primarily due to higher results in both FMC Agricultural Solutions and FMC Lithium. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".

### Other Highlights

On August 1, 2017, we completed the sale of the Omega-3 business to Pelagia AS for $38 million.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to the net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income (charges).

*SEGMENT RESULTS RECONCILIATION*

*(in Millions)*

| 2017 Revenue | Three Months Ended September 30 | 2016 | Nine Months Ended September 30 2017 | 2016 |
| --- | ---: | ---: | ---: | ---: |
| FMC Agricultural Solutions | $551.8 | $558.9 | $1,665.0 | $1,657.0 |
| FMC Lithium | 94.4 | 69.9 | 234.0 | 193.5 |
| **Total revenue** | **$646.2** | **$628.8** | **$1,899.0** | **$1,850.5** |
| **Income from continuing operations before income taxes** |  |  |  |  |
| FMC Agricultural Solutions | $118.4 | $90.1 | $297.1 | $272.8 |
| FMC Lithium | 36.8 | 17.5 | 82.6 | 48.9 |
| **Segment operating profit (1)** | **$155.2** | **$107.6** | **$379.7** | **$321.7** |
| Corporate and other | (25.2) | (18.5) | (74.0) | (54.6) |
| **Operating profit before the items listed below** | **$130.0** | **$89.1** | **$305.7** | **$267.1** |
| Interest expense, net | (18.4) | (15.4) | (51.3) | (46.4) |
| Corporate special (charges) income: |  |  |  |  |
| Restructuring and other (charges) income (2) | (7.1) | (14.1) | (22.3) | (32.7) |
| Non-operating pension and postretirement (charges) income (3) | 3.6 | (0.2) | 12.3 | (2.5) |
| Acquisition-related charges (4) | (48.8) | (4.4) | (78.7) | (16.8) |
| (Provision) benefit for income taxes | 11.6 | (6.5) | (1.1) | (47.4) |
| Discontinued operations, net of income taxes | (15.1) | 31.1 | (157.3) | 74.0 |
| Net income attributable to noncontrolling interests | (0.6) | 0.1 | (1.6) | (2.1) |
| **Net income (loss) attributable to FMC stockholders** | **$55.2** | **$79.7** | **$5.7** | **$193.2** |

(1) Referred to as Segment Earnings.

(2) See Note 8 for details of restructuring and other (charges) income. Below provides the detail of the (charges) income by segment:

*(in Millions)*

|  | Three Months Ended September 30 2017 | 2016 | Nine Months Ended September 30 2017 | 2016 |
| --- | ---: | ---: | ---: | ---: |
| FMC Agricultural Solutions | $(2.2) | $(9.1) | $(7.0) | $(21.6) |
| FMC Lithium | — | — | (2.7) | (0.6) |
| Corporate | (4.9) | (5.0) | (12.6) | (10.5) |
| **Restructuring and other (charges) income** | $(7.1) | $(14.1) | $(22.3) | $(32.7) |

(3) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in the operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees. These expenses are included as a component of the line item “Selling, general and administrative expenses” on the condensed consolidated statements of income (loss).

(4) Charges relate to the expensing of the integration related legal and professional third-party fees associated with the acquisitions. Amounts represent the following:

*(in Millions)*

| Acquisition-related charges - DuPont | Three Months Ended September 30 2017 | 2016 | Nine Months Ended September 30 2017 | 2016 |
| --- | ---: | ---: | ---: | ---: |
| Legal and professional fees (1) | $48.8 | $— | $78.7 | $— |
| Acquisition-related charges - Cheminova (2) (3) |  |  |  |  |
| Legal and professional fees (1) | — | 4.4 | — | 16.8 |
| **Total Acquisition-related charges** | **$48.8** | **$4.4** | **$78.7** | **$16.8** |

(1) On the condensed consolidated statements of income (loss), these charges are included in “Selling, general and administrative expenses.” For more information see Note 3.

(2) For more information on the acquisition-related charges for Cheminova, refer to Note 3 to the consolidated financial statements included within our 2016 Form 10-K.

(3) Acquisition-related charges to integrate Cheminova with FMC Agricultural Solutions were completed at the end of 2016.

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income (loss) attributable to FMC stockholders.” We believe that this measure provides useful information about our operating results to investors. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, and certain Non-GAAP tax adjustments from operating results and discontinued operations allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2017 | Three Months Ended September 30 | 2016 | Nine Months Ended September 30 2017 | 2016 |
| --- | ---: | ---: | ---: | ---: |
| **Net income (loss) attributable to FMC stockholders (GAAP)** | $55.2 | $79.7 | $5.7 | $193.2 |
| Corporate special charges (income), pre-tax | 52.3 | 18.7 | 88.7 | 52.0 |
| Income tax expense (benefit) on Corporate special charges (income) (1) | (17.9) | (5.0) | (30.4) | (14.7) |
| Corporate special charges (income), net of income taxes | $34.4 | $13.7 | $58.3 | $37.3 |
| Discontinued operations attributable to FMC Stockholders, net of income taxes | 15.2 | (30.8) | 157.4 | (73.7) |
| Non-GAAP tax adjustments (2) | (9.4) | (3.9) | (2.8) | 12.2 |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | **$95.4** | **$58.7** | **$218.6** | **$169.0** |

(1) The income tax expense (benefit) on Corporate special charges (income) is determined using the applicable rates in the taxing jurisdictions in which the Corporate special charge or income occurred and includes both current and deferred income tax expense (benefit) based on the nature of the Non-GAAP performance measure.

(2) We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and instead include a Non-GAAP tax provision based upon the projected annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but not limited to: income tax expenses or benefits that are not related to ongoing business operations in the current year; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; excess tax benefits associated with share-based compensation; certain changes in the realizability of deferred tax assets and changes in tax law. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to ongoing operations thereby providing investors with useful supplemental information about FMC's operational performance.

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition-related charges, and other income and expense items.

Information about how each of these items relates to our businesses at the segment level and results by segment is discussed in Note 18 of the condensed consolidated financial statements included within this Form 10-Q and in Note 19 of our consolidated financial statements in our 2016 Form 10-K.

### FMC Agricultural Solutions

*(in Millions)*

| 2017 | Three Months Ended September 30 | 2016 | Nine Months Ended September 30 2017 | 2016 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $551.8 | $558.9 | $1,665.0 | $1,657.0 |
| Operating Profit | 118.4 | 90.1 | 297.1 | 272.8 |

### Revenue

### Three months ended September 30, 2017 vs. 2016

Revenue of $551.8 million decreased approximately 1 percent versus the prior year quarter. Lower volumes in India impacted revenue by 7 percent. Excluding India, higher volumes had a positive impact on the revenue change by approximately 6 percent. Additionally, favorable foreign currency impacted revenue by approximately 1 percent. Offsetting these increases was lower pricing which had a negative impact on the change in revenue of 1 percent. See below for discussion on revenue by region.

### Nine months ended September 30, 2017 vs. 2016

Revenue of $1,665.0 million increased approximately 1 percent versus the prior year period. Overall higher volumes had a favorable impact on revenue by 2 percent period over period while pricing and mix had a 2 percent negative impact. Favorable foreign currency had a minor impact of approximately 1 percent. See below for discussion on revenue by region.

*FMC Agricultural Solutions Combined Revenue by Region*

*(in Millions)*

|  | Three Months Ended September 30 2017 | 2016 | Nine Months Ended September 30 2017 | 2016 |
| --- | ---: | ---: | ---: | ---: |
| Europe, Middle East and Africa (EMEA) (1) | $86.9 | $90.1 | $430.6 | $457.7 |
| North America (2) | 87.1 | 80.1 | 411.0 | 408.6 |
| Latin America (3) | 289.5 | 258.3 | 512.5 | 459.4 |
| Asia (4) | 88.3 | 130.4 | 310.9 | 331.3 |
| **Total FMC Agricultural Solutions Revenue** | **$551.8** | **$558.9** | **$1,665.0** | **$1,657.0** |

(1) Decrease in the three months ended September 30, 2017 was primarily due to a one-time impact of FMC's business in France moving from distribution to direct market access. The decrease in the nine months ended September 30, 2017 was primarily due to the late start to the season in Northwestern Europe in the first quarter of 2017 as well as the impact of France moving from distribution to direct market access, partially offset by the favorable pricing and new product launches in cereal herbicides and fungicides in the three months ended June 30, 2017.

(2) Increase in the three months ended September 30, 2017 was primarily due to strong growth in post-emergent herbicides and foliar insecticides. The increase in the nine months ended September 30, 2017 was primarily due to the same reasons mentioned in the three months ended September 30, 2017 as well as stronger demand in the first half of the year for pre-emergent herbicides, partially offset by lower pricing earlier in the year.

(3) Increase in the three months ended September 30, 2017 was primarily driven by volume growth in pre-emergent herbicides in Argentina and robust volume growth in Brazil. The increase in the nine months ended September 30, 2017 was due to the continued growth in pre-emergent herbicides previously discussed coupled with a continual improvement in the fundamentals of Brazil's cotton and sugarcane markets.

(4) Decrease for the three months ended September 30, 2017 was primarily due to actions taken to destock existing sales channels ahead of market access integration with the acquired DuPont business in India. Excluding India, regional volume for the nine months ended September 30, 2017 increased due to successful product launches in China, strong demand for rice insecticides in Indonesia and increased herbicide demand in Australia.

### Operating Profit

### Three months ended September 30, 2017 vs. 2016

FMC Agricultural Solutions' operating profit of $118.4 million increased by approximately 31 percent compared to the year-ago quarter. The increase was mainly driven by higher volumes, excluding India, and lower costs from cost benefits associated with our Brazilian business as well as overall lower operating costs which contributed approximately 20 percent and 16 percent, respectively, to the increase. Additionally, favorable foreign currency impacted the change in earnings by approximately 9 percent. These increases were offset by lower pricing which had a negative impact on profit of 8 percent as well as the lower volumes in India which contributed 6 percent to the change.

### Nine months ended September 30, 2017 vs. 2016

Operating profit of $297.1 million increased approximately 9 percent versus the prior year period. The increase was driven by overall higher volumes and lower costs which contributed approximately 7 percent and 5 percent, respectively, to the increase. Additionally, favorable foreign currency impacted the change in earnings by approximately 6 percent. Offsetting these increases were unfavorable price and product mix which contributed 9 percent to the change.

### Outlook

For 2017, full-year segment revenue is expected to be approximately $2.5 billion to $2.6 billion, which includes a contribution of $2.3 billion to $2.4 billion from Legacy FMC, and full-year segment earnings are expected to be in the range of $465 million to $485 million, which includes a contribution of $425 million to $445 million from Legacy FMC.

### FMC Lithium

*(in Millions)*

| 2017 | Three Months Ended September 30 | 2016 | Nine Months Ended September 30 2017 | 2016 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $94.4 | $69.9 | $234.0 | $193.5 |
| Operating Profit | 36.8 | 17.5 | 82.6 | 48.9 |

### Three months ended September 30, 2017 vs. 2016

Revenue of $94.4 million increased by approximately 35 percent versus the prior-year quarter, driven by successful production and sales from the new hydroxide facilities in China. Higher pricing contributed 16 percent to the revenue increase and higher volumes impacted revenue by 19 percent. Foreign currency had a minimal impact on the change in revenue.

Segment operating profit of $36.8 million increased $19.3 million versus the year ago quarter. The favorable pricing noted above impacted results by approximately $11 million. Additionally, the higher volumes noted above increased operating profit by approximately $8 million. Both unfavorable foreign currency impacts and lower operating costs each contributed to less than $1 million on the change in profit.

### Nine months ended September 30, 2017 vs. 2016

Revenue of $234.0 million increased by approximately 21 percent versus the prior-year period. Higher pricing contributed 18 percent to the revenue increase while higher volumes impacted revenue by 3 percent. Foreign currency had a minimal impact on the change in revenue.

Segment operating profit of $82.6 million increased $33.7 million versus the prior-year period. The favorable pricing noted above impacted results by approximately $35 million. Favorable foreign currency impacted operating profit by approximately $1 million. The higher volumes noted above contributed to the increased operating profit by $4 million. These increases were offset by higher operating costs, which impacted results by approximately $7 million driven by higher raw material and energy prices as well as expansion related costs.

### Outlook

Segment earnings are now expected to be between $124 million and $128 million for the full year of 2017, an increase of 79 percent over 2016 at the mid-point of the range and $6 million higher than the previous range.

We continue to invest in FMC Lithium and to move forward with our plans to expand our lithium hydroxide operations and carbonate capacity. We will continue to operate FMC Lithium as a standalone business within FMC. Our strategic intent is that we will spin off FMC Lithium as a separate, publicly traded company.

### Other Results of Operations

#### Corporate and other

Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for LIFO related charges that are included as a component of "Cost of sales and services" on the condensed consolidated statements of income (loss).

### Three months ended September 30, 2017 vs. 2016

Corporate and other expenses of $25.2 million in the third quarter of 2017 increased by $6.7 million from $18.5 million in the same period in 2016. The increase was primarily driven by approximately $3 million of corporate incentives due to higher business results and share-based compensation. Additionally, the prior period included approximately $2 million of LIFO income that did not recur in 2017.

### Nine months ended September 30, 2017 vs. 2016

Corporate and other expenses of $74.0 million in the nine months ended September 30, 2017 increased by $19.4 million from $54.6 million in the same period in 2016. The increase was driven by higher corporate incentives and other personnel related costs of approximately $3 million each. The LIFO impact discussed above also impacted the nine months ended results by approximately $4 million. The remaining increase was due to other corporate items including corporate facility costs, foreign exchange losses and other shared corporate costs.

#### Interest expense, net

### Three months ended September 30, 2017 vs. 2016

Interest expense, net for the third quarter of 2017 of $18.4 million increased as compared to the third quarter of 2016 of $15.4 million primarily due to higher foreign debt balances and increases in interest rates which contributed $3.0 million and $0.8 million, respectively, to the increase. Partially offsetting the increases were lower long-term debt balances which decreased interest expense, net by $1.3 million.

### Nine months ended September 30, 2017 vs. 2016

Interest expense, net for the first three quarters of 2017 of $51.3 million increased as compared to the first three quarters of 2016 of $46.4 million primarily due to higher foreign debt balances and increases in interest rates which contributed $3.8 million and $2.6 million, respectively, to the increase. Partially offsetting the increases were lower long-term debt balances which decreased interest expense, net by $1.3 million.

#### Corporate special charges (income)

#### Restructuring and other charges (income)

*(in Millions)*

|  | Three Months Ended September 30 2017 | 2016 | Nine Months Ended September 30 2017 | 2016 |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges and asset disposals | $4.4 | $5.8 | $7.1 | $14.7 |
| Other charges (income), net | 2.7 | 8.3 | 15.2 | 18.0 |
| Total restructuring and other charges (income) | $7.1 | $14.1 | $22.3 | $32.7 |

### Three months ended September 30, 2017 vs. 2016

Restructuring and asset disposal charges in 2017 of $4.4 million were primarily associated with impairment charges on intangible assets within both FMC Agricultural Solutions and Corporate.

Restructuring and asset disposal charges in 2016 of $5.8 million were primarily associated with the Cheminova restructuring to integrate the business into our existing FMC Agricultural Solutions segment for the quarter.

Other charges (income), net in 2017 of $2.7 million were composed of environmental related charges.

Other charges (income), net in 2016 of $8.3 million were primarily related to $8.1 million of environmental related charges.

The liabilities associated with the restructuring charges listed above are also included within Note 8 to the condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.

#### Non-operating pension and postretirement charges

The income for the three months ended September 30, 2017 was $3.6 million compared to a charge of $0.2 million for the three months ended September 30, 2016. The decrease in charges was primarily due to the change in estimate of amortizing gains and losses over the expected lifetime of the inactive population rather than the average remaining service period of active participants as described in our 2016 Form 10-K. The gain/loss amortization period for the U.S. qualified pension plan increased from about eight years to about nineteen years as a result of this change. The income from amortization was slightly offset by a $1.2 million settlement charge related to the non-qualified plan in the U.S. See Note 14 to the condensed consolidated financial statements included in this Form 10-Q for more information. These expenses are included as a component of the line item "Selling, general and administrative expenses" on the condensed consolidated statements of income (loss).

#### Acquisition-related charges

A detailed description of the acquisition-related charges is included in Note 18 to the condensed consolidated financial statements included within this Form 10-Q.

### Nine months ended September 30, 2017 vs. 2016

Restructuring and asset disposal charges in 2017 of $7.1 million were primarily associated with impairment charges of intangible assets within both FMC Agricultural Solutions and Corporate of $4.4 million. Additionally, there was $2.7 million of other Corporate charges.

Restructuring and asset disposal charges in 2016 of $14.7 million were primarily associated with the Cheminova restructuring to integrate the business into our existing FMC Agricultural Solutions segment for the quarter.

Other charges (income), net in 2017 of $15.2 million were primarily related to $8.3 million of environmental related charges. Other charges (income), net also included $4.7 million of exit costs resulting from the termination and deconsolidation of a variable interest entity that was previously consolidated and was part of our FMC Agricultural Solutions segment. See Note 8 within the condensed consolidated financial statements included in this Form 10-Q for more information.

Other charges (income), net in 2016 of $18.0 million were primarily related to $17.1 million of environmental related charges as well as $4.2 million of charges associated with currency devaluation within Argentina as a result of deliberate actions by the government of that country. These charges were offset by other miscellaneous income of $3.3 million.

#### Non-operating pension and postretirement charges

The income for the nine months ended September 30, 2017 was $12.3 million compared to a charge of $2.5 million for the nine months ended September 30, 2016. The decrease in charges was primarily due to the same reason as discussed in the three months ended discussion above. The income from amortization was slightly offset by a $2.0 million settlement charge related to the non-qualified plan in the U.S. See Note 14 to the condensed consolidated financial statements included in this Form 10-Q for more information. These expenses are included as a component of the line item "Selling, general and administrative expenses" on the condensed consolidated statements of income (loss).

#### Acquisition-related charges

A detailed description of the acquisition-related charges is included in Note 18 to the condensed consolidated financial statements included within this Form 10-Q.

#### Provision for income taxes

A significant amount of our earnings is generated by our foreign subsidiaries (e.g. Denmark and Hong Kong), which tax earnings at lower rates than the United States federal statutory rate. Our future effective tax rates may be materially impacted by numerous items including: a future change in the composition of earnings from foreign and domestic tax jurisdictions, as earnings in foreign jurisdictions are typically taxed at more favorable rates than the United States federal statutory rate; accounting for uncertain tax positions; business combinations; expiration of statute of limitations or settlement of tax audits; changes in valuation allowance; changes in tax law; and the potential decision to repatriate certain future foreign earnings on which United States taxes have not been previously accrued.

### Three months ended September 30, 2017 vs. 2016

Provision for income taxes for the three months ended September 30, 2017 was a benefit of $11.6 million resulting in an effective tax rate of negative 19.6 percent. Provision for income taxes for the three months ended September 30, 2016 was $6.5 million resulting in an effective tax rate of 11.8 percent. Additional detail explaining the change in the GAAP effective tax rate is presented in Note 15 to the condensed consolidated financial statements included within this Form 10-Q. Below is a table that adjusts our income and taxes for the effect of corporate special charges and certain tax adjustments. We believe showing this reconciliation of our GAAP to Non-GAAP effective tax rate provides investors with useful supplemental information about our tax rate on the core underlying business.

*(in Millions)*

|  | Three Months Ended September 30 2017 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate | 2016 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **GAAP - Continuing operations** | $59.3 | $(11.6) | (19.6)% | $55.0 | $6.5 | 11.8% |
| Corporate special charges | 52.3 | 17.9 |  | 18.7 | 5.0 |  |
| Tax adjustments (1) |  | 9.4 |  |  | 3.9 |  |
| **Non-GAAP - Continuing operations** | $111.6 | $15.7 | **14.1%** | $73.7 | $15.4 | **20.9%** |

(1) Refer to note 2 of the Adjusted Earnings Reconciliation of this Form 10-Q for an explanation of tax adjustments.

The primary drivers for the decrease in the third quarter effective tax rate for 2017 compared to 2016 are shown in the table above. The remaining change was due to reduced domestic earnings in our FMC Agricultural Solutions business and the impact of the full integration of Cheminova into our global supply chain.

### Nine months ended September 30, 2017 vs. 2016

Provision for income taxes for the nine months ended September 30, 2017 was $1.1 million resulting in an effective tax rate of 0.7 percent. Provision for income taxes for the nine months ended September 30, 2016 was $47.4 million resulting in an effective tax rate of 28.1 percent. Additional detail explaining the change in the GAAP effective tax rate is presented in Note 15 to the condensed consolidated financial statements included within this Form 10-Q. Below is a table that adjusts our income and taxes for the effect of corporate special charges and certain tax adjustments. We believe showing this reconciliation of our GAAP to Non-GAAP effective tax rate provides investors with useful supplemental information about our tax rate on the core underlying business.

*(in Millions)*

|  | Nine Months Ended September 30 2017 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate | 2016 Income (Expense) | Tax Provision (Benefit) | Effective Tax Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **GAAP - Continuing operations** | $165.7 | $1.1 | 0.7% | $168.7 | $47.4 | 28.1% |
| Corporate special charges | 88.7 | 30.4 |  | 52.0 | 14.7 |  |
| Tax adjustments (1) |  | 2.8 |  |  | (12.2) |  |
| **Non-GAAP - Continuing operations** | $254.4 | $34.3 | **13.5%** | $220.7 | $49.9 | **22.6%** |

(1) Refer to note 2 of the Adjusted Earnings Reconciliation of this Form 10-Q for an explanation of tax adjustments.

The primary drivers for the decrease in the year-to-date effective tax rate for 2017 compared to 2016 are shown in the table above. The remaining change was due to reduced domestic earnings in our FMC Agricultural Solutions business and the impact of the full integration of Cheminova into our global supply chain.

#### Discontinued operations, net of income taxes

Our discontinued operations represent our discontinued FMC Health and Nutrition as well as adjustments to retained liabilities from other previously discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.

### Three months ended September 30, 2017 vs. 2016

Discontinued operations, net of income taxes represented a loss of $15.1 million for the three months ended September 30, 2017, compared to income of $31.1 million for the three months ended September 30, 2016. The results for the three months ended September 30, 2017 included a $25.0 million ($16.3 million, net of tax) environmental remediation charge for one site as discussed in Note 11. Additionally, our discontinued FMC Health and Nutrition's results for the three months ended decreased by $26.1 million year over year, primarily due to an incremental tax cost of $14.7 million related to certain legal entity restructuring executed during the third quarter to facilitate the FMC Health and Nutrition divestiture, as well as lower earnings. Refer to Note 10 to the condensed consolidated financial statements included within this Form 10-Q for further information.

### Nine months ended September 30, 2017 vs. 2016

Discontinued operations, net of income taxes represented a loss of $157.3 million for the nine months ended September 30, 2017, compared to income of $74.0 million for the nine months ended September 30, 2016. The results for the nine months ended September 30, 2017 include an impairment charge of approximately $168 million ($148 million, net of tax) to write down our Omega-3 business to its estimated fair value less cost to sell. Refer to Note 10 to the condensed consolidated financial statements included within this Form 10-Q for further information.

#### Net income (loss) attributable to FMC stockholders

### Three months ended September 30, 2017 vs. 2016

Net income attributable to FMC stockholders decreased to $55.2 million from $79.7 million in the prior-year quarter. The decrease was primarily due to a loss from discontinued operations, net of income taxes as discussed above along with higher selling, general and administrative expenses due to acquisition costs, offset partially by increased earnings from continuing operations.

### Nine months ended September 30, 2017 vs. 2016

Net income attributable to FMC stockholders decreased to $5.7 million from income of $193.2 million in the prior-year period. The decrease was primarily due to the impairment charge, associated with our Omega-3 business, which was recorded to discontinued operations as discussed above.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at September 30, 2017 and December 31, 2016, were $93.8 million and $64.2 million, respectively. Of the cash and cash equivalents balance at September 30, 2017, $93.3 million were held by our foreign subsidiaries. Our intent is to reinvest indefinitely the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings, however, in the first quarter of 2017 we changed our assertion on unremitted earnings for certain foreign subsidiaries as a result of our expected sale of our discontinued FMC Health and Nutrition segment and have recorded the taxes that would be payable upon such repatriation within discontinued operations.

At September 30, 2017, we had total debt of $1,707.1 million as compared to $1,893.0 million at December 31, 2016. Total debt included $1,492.9 million and $1,798.8 million of long-term debt (excluding current portions of $105.7 million and $2.4 million) at September 30, 2017 and December 31, 2016, respectively. As of September 30, 2017, we were in compliance with all of our debt covenants. See Note 9 in the condensed consolidated financial statements included in this Form 10-Q for further details.

Short-term debt, which consists of borrowings under our commercial paper program as well as short-term foreign borrowings, increased from $94.2 million at December 31, 2016 to $214.2 million at September 30, 2017.

Our commercial paper program allows us to borrow at rates generally more favorable than those available under our credit facility. We have used proceeds from the commercial paper program for general corporate purposes. At September 30, 2017, we had $8.4 million borrowed under the commercial paper program and the average effective interest rate on these borrowings during the period was 1.5%.

On November 1, 2017, we borrowed $1.5 billion under our previously announced senior unsecured term loan facility. $1.2 billion of the proceeds were used to finance the Acquisition. The remaining $300 million will be held as cash to meet various obligations related to the transaction, primarily tax payable on the sale FMC Health and Nutrition, with any excess cash used to repay various outstanding debt facilities.

### Statement of Cash Flows

*Cash provided (required) by operating activities of continuing operations was $272.5 million and $266.5 million for the nine months ended September 30, 2017 and 2016, respectively.*

The table below presents the components of net cash provided (required) by operating activities of continuing operations.

*(in Millions)*

| 2017 | Nine Months Ended September 30 | 2016 |
| --- | ---: | ---: |
| Income from continuing operations before equity in (earnings) loss of affiliates, interest expense, net and income taxes | $216.8 | $214.7 |
| Corporate special charges and depreciation and amortization (1) | 159.9 | 127.2 |
| **Operating income before depreciation and amortization (Non-GAAP)** | **$376.7** | **$341.9** |
| Change in trade receivables, net (2) | 286.8 | 245.6 |
| Change in inventories (3) | (108.1) | (36.2) |
| Change in accounts payable (4) | 104.6 | (20.7) |
| Change in accrued customer rebates (5) | 123.6 | 160.2 |
| Change in advance payments from customers (6) | (233.6) | (244.9) |
| Change in all other operating assets and liabilities (7) | (105.0) | (3.6) |
| **Cash basis operating income (Non-GAAP)** | **$445.0** | **$442.3** |
| Restructuring and other spending (8) | (4.2) | (11.5) |
| Environmental spending, continuing, net of recoveries (9) | (11.5) | (19.8) |
| Pension and other postretirement benefit contributions (10) | (51.1) | (40.7) |
| Net interest payments (11) | (57.6) | (46.7) |
| Tax payments, net of refunds (11) | (12.9) | (39.8) |
| Excess tax benefits from share-based compensation | — | (0.5) |
| Acquisition legal and professional fees (12) | (35.2) | (16.8) |
| **Cash provided (required) by operating activities of continuing operations** | **$272.5** | **$266.5** |

(1) Represents the sum of corporate special charges and depreciation and amortization.

(2) The change in cash flows related to trade receivables in 2017 was primarily driven by timing of collections. Collection timing is more pronounced in our FMC Agricultural Solutions business where sales, particularly in Brazil, have terms significantly longer than the rest of our businesses. Additionally, timing of collection is impacted as amounts for both periods include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks. During the nine months ended September 30, 2017, we collected approximately $603 million of receivables in Brazil. A significant proportion of the collections in Brazil are coming from those accounts that were past due at the start of the year, improving the quality of the remaining receivable balance. Additionally, the nine months ended September 30, 2016 benefited from a one-off early collection in North America which did not repeat.

(3) Inventory changes and the seasonal nature of the business within the different hemispheres are adjusted accordingly to take into consideration the change in market conditions primarily in FMC Agricultural Solutions.

(4) The change in cash flows related to accounts payable is primarily driven by the timing of payments made to suppliers and vendors.

(5) These rebates are associated with our FMC Agricultural Solutions segment in North America and Brazil and generally settle in the fourth quarter of each year. The changes year over year are primarily associated with the mix in sales eligible for rebates and incentives in 2017 compared to 2016 and timing of rebate payments.

(6) Advanced payments are primarily associated with our FMC Agricultural Solutions business within North America and these payments are received in the fourth quarter of each year and recorded as deferred revenue on the balance sheet at December 31. Revenue associated with advance payments is recognized, generally in the first quarter of each year, as shipments are made and title, ownership and risk of loss pass to the customer.

(7) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities, including guarantees issued to vendors under our vendor finance program.

(8) See Note 8 in our consolidated financial statements included in this Form 10-Q for further details.

(9) Included in the period presented are environmental charges for environmental remediation at our operating sites of $8.3 million and $17.1 million, respectively. The amounts in 2017 will be spent in future years. The amounts represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.

(10) There were $44.0 million in voluntary contributions to our U.S. defined benefit plans in 2017 and $35.0 million in 2016.

(11) Amounts shown in the chart represent net payments of our continuing operations. Net interest payments of $15.1 million and $14.8 million and tax payments, net of refunds of $8.1 million and $12.1 million were allocated to discontinued operations for the nine months ended September 30, 2017 and 2016, respectively.

(12) 2017 activity represents payments for legal and professional fees associated with the previously announced acquisition of certain assets relating to DuPont's Crop Protection business. 2016 activity represents payments for legal and professional fees associated with the Cheminova acquisition. See Note 3 to the condensed consolidated financial statements included in this Form 10-Q for more information.

*Cash provided (required) by operating activities of discontinued operations was $47.0 million and $121.6 million for the nine months ended September 30, 2017 and 2016, respectively.*

Cash provided (required) by operating activities of discontinued operation is directly related to environmental, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities. Amounts also include operating activities related to our discontinued FMC Health and Nutrition segment.

*Cash provided (required) by investing activities of continuing operations was $(70.0) million and $(74.9) million for the nine months ended September 30, 2017 and 2016, respectively.*

The decrease in cash required during the nine months ended September 30, 2017, as compared to the same period in 2016 was due to less capital expenditures, offset by other various investing activities.

*Cash provided (required) by investing activities of discontinued operations was $20.2 million and $(22.3) million for the nine months ended September 30, 2017 and September 30, 2016.*

Cash provided (required) by investing activities of discontinued operations is directly associated with the capital expenditures of FMC Health and Nutrition. Cash provided in the current period includes the proceeds from the sale of the Omega-3 business for $38.0 million.

*Cash provided (required) by financing activities was $(244.3) million and $(240.4) million for the nine months ended September 30, 2017 and 2016, respectively.*

The change period over period in financing activities is primarily due to the increase in cash provided by short term debt and increases in proceeds from borrowings of long-term debt, offset by higher repayments of long term debt in the nine months ended September 30, 2017.

### Other potential liquidity needs

Our cash needs outside of the DuPont crop protection acquisition and related integration expenses for 2017 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At September 30, 2017, our remaining borrowing capacity under our credit facility was $1,355.5 million (which includes borrowing capacity under our commercial paper program).

Projected 2017 capital expenditures as well as expenditures related to contract manufacturers are expected to be relatively flat compared to 2016 levels.

Projected 2017 spending includes approximately $50 million to $55 million of net environmental remediation spending. This spending does not include expected spending on capital projects relating to environmental control facilities or expected spending for environmental compliance costs, which we will include as a component of costs of sales and services to the condensed consolidated statements of income (loss) since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we have made voluntary cash contributions of approximately $44 million during 2017. These contributions are in excess of the minimum requirements. We do not expect to make any further contributions to our U.S. defined benefit pension plan during 2017.

For the nine months ended September 30, 2017 and 2016, we paid dividends of $66.6 million and $66.4 million, respectively. On October 19, 2017, we paid dividends totaling $22.3 million to our shareholders of record as of September 29, 2017. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of September 30, 2017.

During the nine months ended September 30, 2017, no shares were repurchased under the publicly announced repurchase program. At September 30, 2017, $238.8 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans.

### Commitments and Contingencies

See Note 17 to the condensed consolidated financial statements included in this Form 10-Q.

### Contractual Commitments

Information related to our contractual commitments at December 31, 2016 can be found in a table included within Part II, Item 7 of our 2016 Form 10-K. There have been no significant changes to our contractual commitments during the nine months ended September 30, 2017.

### Climate Change

A detailed discussion related to climate change can be found in Part II, Item 7 of our 2016 Form 10-K.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair-Value Measurements

See Note 16 to the condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At September 30, 2017, our financial instrument position was a net asset of $1.4 million compared to a net liability of $2.5 million at December 31, 2016. The change in the net financial instrument position was primarily due to change in exchange rates.

Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.

### Commodity Price Risk

Energy costs are diversified among electricity and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and electricity. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at September 30, 2017 and December 31, 2016, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position on Consolidated Balance Sheets | Hedged energy exposure vs. Energy market pricing 10% Increase | 10% Decrease |
| --- | ---: | ---: | ---: |
| **Net asset (liability) position at September 30, 2017** | $0.2 | $0.5 | $(0.1) |
| **Net asset (liability) position at December 31, 2016** | $2.0 | $3.3 | $0.8 |

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the Euro, the U.S. dollar versus the Chinese yuan, the U.S. dollar versus the Brazilian real and the U.S. dollar versus the Argentine peso. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at September 30, 2017 and December 31, 2016, with all other variables (including interest rates) held constant.

*(in Millions)*

|  | Net Asset / (Liability) Position on Consolidated Balance Sheets | Hedged Currency vs. Functional Currency 10% Strengthening | 10% Weakening |
| --- | ---: | ---: | ---: |
| **Net asset (liability) position at September 30, 2017** | $1.2 | $14.8 | $(12.9) |
| **Net asset (liability) position at December 31, 2016** | $(4.5) | $31.9 | $(39.0) |

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of September 30, 2017 and December 31, 2016, we had no interest rate swap agreements.

Our debt portfolio, at September 30, 2017, is composed of 72 percent fixed-rate debt and 28 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our 2014 Term Loan Facility, Revolving Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at September 30, 2017, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $3.6 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $3.6 million for the nine months of September 30, 2017.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,536 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2017, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended September 30, 2017, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of September 30, 2017, the related condensed consolidated statements of income (loss) and comprehensive income (loss), for the three‑month and nine-month periods ended September 30, 2017 and 2016, and the related condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2017 and 2016. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2016, and the related consolidated statements of income (loss), comprehensive income (loss), changes in equity, and cash flows for the year then ended (not presented herein); and in our report dated February 28, 2017, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2016, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

**/s/** KPMG LLP

Philadelphia, Pennsylvania

November 7, 2017

## Risk factors

As filed, 3,691 characters.

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part 1, Item 1A "Risk Factors" of our 2016 Form 10-K. The risks described in our Form 10-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could suffer.

### Forward-Looking Information

Certain statements contained in this communication may constitute “forward-looking statements” and provide other than historical information. In some cases, we have identified forward-looking statements by such words or phrases as “will likely result,” “is confident that,” “expect,” “expects,” “should,” “could,” “may,” “will continue to,” “believe,” “believes,” “anticipates,” “predicts,” “forecasts,” “estimates,” “projects,” “potential,” “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the Company based on currently available information. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. The factors that could cause actual results to differ materially include the following: the possibility that the Company may be unable to achieve expected synergies and operating efficiencies within the expected time-frames or at all and to successfully integrate the DuPont Crop Protection Business into the Company’s Agricultural Solutions business; such integration may be more difficult, time-consuming or costly than expected; revenues following the transaction may be lower than expected; operating costs, customer loss and business disruption (including, without limitation, difficulties in maintaining relationships with employees, customers, clients or suppliers) may be greater than expected following the closing of the transaction; the retention of certain key employees; risks associated with the disruption of management’s attention from ongoing business operations during the integration period; the Company’s ability to meet expectations regarding the accounting and tax treatments of the transaction the impact of indebtedness incurred by the Company in connection with the transaction and the potential impact on the rating of indebtedness of the Company; and any other effects of the transaction on the Company, including those of the Company’s future financial condition, operating results, strategy and plans; and other factors detailed in the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) for the fiscal year ended December 31, 2016 and the Company’s other filings with the SEC, which are available at http://www.sec.gov and on the Company’s website at www.fmc.com. We wish to caution readers not to place undue reliance on any forward-looking statements contained herein, which speak only as of the date made. We specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Filed Nov 7, 2017.
Source: SEC EDGAR, the filing index for accession 0000037785-17-000067. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
